GT Biopharma, Inc. (GTBP)
0.6598
+0.01
(+1.51%)
USD |
NASDAQ |
Dec 12, 16:00
0.6593
0.00 (0.00%)
After-Hours: 20:00
GT Biopharma Research and Development Expense (Quarterly): 0.634M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Geron Corp. | 21.07M |
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| SELLAS Life Sciences Group, Inc. | 4.216M |
| Xencor, Inc. | 54.37M |
| Zymeworks, Inc. | 35.58M |